期刊文献+

血府逐瘀汤对宫颈癌患者疼痛程度、致痛因子和生活质量的影响

Effect of Xuefu Zhuyu decoction on the pain levels,pain causing factors,and quality of life in patients with cervical cancer
下载PDF
导出
摘要 目的探讨血府逐瘀汤对宫颈癌患者疼痛程度、致痛因子和生活质量的影响。方法依据治疗方式的不同将90例宫颈癌患者分为观察组(n=46)和对照组(n=44),两组患者均接受顺铂+紫杉醇(TP)方案化疗,对照组患者在此基础上接受盐酸羟考酮缓释片治疗,观察组患者在对照组基础上联合血府逐瘀汤治疗。比较两组患者疼痛程度[数字分级评分法(NRS)]、中医证候积分、致痛因子[一氧化氮(NO)、前列腺素E(2 PGE2)]、生活质量[欧洲癌症研究与治疗组织生命质量测定量表(EORTC QLQ-C30)]。结果治疗1、2、3周,两组患者的NRS评分均低于本组治疗前,观察组患者NRS评分均低于对照组,差异均有统计学意义(P﹤0.05)。治疗后,两组患者中医证候积分均低于本组治疗前,观察组患者中医证候积分低于对照组,差异均有统计学意义(P﹤0.05)。治疗后,两组患者NO、PGE2水平均低于本组治疗前,观察组患者NO、PGE2水平均低于对照组,差异均有统计学意义(P﹤0.05)。治疗后,两组患者EORTC QLQ-C30各维度评分均高于本组治疗前,观察组患者EORTC QLQ-C30各维度评分均高于对照组,差异均有统计学意义(P﹤0.05)。结论宫颈癌患者采取血府逐瘀汤治疗可缓解癌因性疼痛,降低致痛因子水平,改善临床症状,提高生活质量。 Objective To explore the effect of Xuefu Zhuyu decoction on the pain levels,pain causing factors,and quality of life in patients with cervical cancer.Method According to different treatment methods,90 cervical cancer patients were divided into observation group(n=46)and control group(n=44).Both groups received cisplatin+paclitaxel(TP)regimen chemotherapy,the control group received oxycodone hydrochloride prolonged-release tablets,while the observation group received Xuefu Zhuyu decoction on the base of the control group.The pain levels[numerical rating scale(NRS)],traditional Chinese medicine(TCM)symptom scores,pain causing factors[nitric oxide(NO),prostaglandin E2(PGE2)]and quality of life[European Organization for Research and Treatment of Cancer quality of life questionnaire core 30(EORTC QLQ-C30)]were compared between the two groups.Result After 1,2,and 3 weeks of treatment,the NRS scores of the two groups were lower than those before treatment,and the NRS scores of the observation group were lower than those of the control group,and the differences were statistically significant(P<0.05).After treatment,the TCM syndrome scores of both groups were lower than those before treatment,the TCM syndrome score of the observation group was lower than that of the control group,and the differences were statistically significant(P<0.05).After treatment,the levels of NO and PGE2 in both groups were lower than those before treatment,the levels of NO and PGE2 in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).After treatment,the scores of each dimension of EORTC QLQ-C30 in both groups were higher than those before treatment,the scores of each dimension of EORTC QLQ-C30 in the observation group were higher than those in the control group,and the differences were statistically significant(P<0.05).Conclusion The cervical cancer patients treatment with Xuefu Zhuyu decoction can alleviate cancer-related pain,reduce levels of pain causing factors,improve clinical symptoms,and enhance quality of life.
作者 张丹焕 刘蔚霞 马素娟 ZHANG Danhuan;LIU Weixia;MA Sujuan(Department of Obstetrics and Gynecology,the First Affiliated Hospital of He’nan University of Traditional Chinese Medicine,Zhengzhou 450000,He’nan,China)
出处 《癌症进展》 2024年第18期2065-2068,共4页 Oncology Progress
关键词 宫颈癌 癌因性疼痛 血府逐瘀汤 疼痛程度 生活质量 cervical cancer cancer-related pain Xuefu Zhuyu decoction pain level quality of life
  • 相关文献

参考文献9

二级参考文献132

  • 1蒋艳,黎雪梅,涂春燕,刘守福.洛铂和顺铂分别联合紫杉醇治疗晚期局部宫颈癌的5年随访观察[J].热带医学杂志,2022,22(4):563-567. 被引量:7
  • 2赵晴晴,卞方,王水英,晋鑫.康莱特注射液联合化疗对晚期肺癌患者癌痛症状、免疫功能及短期疗效的影响[J].辽宁中医杂志,2020(10):100-104. 被引量:19
  • 3李静.蟾乌巴布膏在晚期肺癌患者疼痛护理中的应用[J].上海护理,2007,7(1):24-25. 被引量:14
  • 4Aaronson NK,Ahmedzai S,Bergman B,et al.The European Organization for Research and Treatment of Cancer QLQ-C30:A qualityof-life instrument for use in international clinical trials in oncology[J].Journal of the National Cancer Institute,1993,85(5):365-376.
  • 5Garratt A,Schmidt L,Mackintosh A,et al.Quality of life measurement:bibliographic study of patient assessed health outcome measures[J].British Medical Journal,2002,324 (15):1-5.
  • 6Park KU.Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC core quality of Life Questionnaire (QLQ-C30) in a Korean sample[J].Oncology,2008,74(Suppl 1):7-12.
  • 7Bjorner JB,Petersen MA,Groenvold M,et al.Use of item response theory to develop a shortened version of the EORTC QLQ-C30 emotional functioning scale[J].Qual Life Res,2004,13(10):1683-1697.
  • 8Kobayashi K,Green J,Shimonagayoshi M,et al.Validation of the care notebook for measuring physical,mental and life wellbeing of patients with cancer[J].Quality of Life Research,2005,14(4):1 035-1 043.
  • 9Greisinger A J,Weitzner MA,Lormor R J,et al.Development of a quality of life module for end-stage cancer patients[M].Los Angeles:UDG Press,1995:201-239.
  • 10Shin DW,Choi JE,Miyashita M,et al.Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 15-Palliative Care[J].J Pain Symptom Manage,2011,41:478-484.

共引文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部